Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

De novo induction of genetically engineered brain tumors in mice using plasmid DNA.

Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, Long C, Demorest ZL, Zamora EA, Low WC, SantaCruz K, Largaespada DA, Ohlfest JR.

Cancer Res. 2009 Jan 15;69(2):431-9. doi: 10.1158/0008-5472.CAN-08-1800.

2.

Genetically engineered mouse models of brain cancer and the promise of preclinical testing.

Huse JT, Holland EC.

Brain Pathol. 2009 Jan;19(1):132-43. doi: 10.1111/j.1750-3639.2008.00234.x. Review.

3.

Emerging role of new transgenic mouse models in glioma research.

Sonabend AM, Ulasov IV, Lesniak MS.

Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S7-13. doi: 10.1586/14737140.7.12s.S7. Review.

PMID:
18076321
4.

Modeling gliomagenesis with somatic cell gene transfer using retroviral vectors.

Uhrbom L, Holland EC.

J Neurooncol. 2001 Jul;53(3):297-305. Review.

PMID:
11718262
5.

Oncogenes: cause or consequence in the development of glial tumors.

Akbasak A, Sunar-Akbasak B.

J Neurol Sci. 1992 Sep;111(2):119-33. Review.

PMID:
1331337
6.

Molecular biology of pediatric gliomas.

Raffel C.

J Neurooncol. 1996 May-Jun;28(2-3):121-8. Review.

PMID:
8832457
7.
8.

Technologically advanced cancer modeling in mice.

Tuveson DA, Jacks T.

Curr Opin Genet Dev. 2002 Feb;12(1):105-10. Review.

PMID:
11790563
9.

Genetically engineered mouse models of diffuse gliomas.

Schmid RS, Vitucci M, Miller CR.

Brain Res Bull. 2012 May 1;88(1):72-9. doi: 10.1016/j.brainresbull.2011.06.002. Epub 2011 Jun 13. Review.

PMID:
21684324
10.

Only in congenial soil: the microenvironment in brain tumorigenesis.

Rubin JB.

Brain Pathol. 2009 Jan;19(1):144-9. doi: 10.1111/j.1750-3639.2008.00235.x. Review.

PMID:
19076779
11.

Oncogenes and glial tumors.

Watkins D, Rouleau GA.

Rev Neurol (Paris). 1992;148(6-7):402-7. Review.

PMID:
1448659
12.

Intravenous, non-viral RNAi gene therapy of brain cancer.

Pardridge WM.

Expert Opin Biol Ther. 2004 Jul;4(7):1103-13. Review.

PMID:
15268677
13.

Genetics and malignant progression of human brain tumours.

Furnari FB, Huang HJ, Cavenee WK.

Cancer Surv. 1995;25:233-75. Review.

PMID:
8718522
14.

Applications of mouse glioma models in preclinical trials.

Hu X, Holland EC.

Mutat Res. 2005 Aug 25;576(1-2):54-65. Review.

PMID:
16011838
15.

Review: insights gained from modelling high-grade glioma in the mouse.

Rankin SL, Zhu G, Baker SJ.

Neuropathol Appl Neurobiol. 2012 Jun;38(3):254-70. doi: 10.1111/j.1365-2990.2011.01231.x. Review.

16.

[Functional significance of p53 gene mutation in astrocytic neoplasms].

Tada M.

No To Shinkei. 1998 Jun;50(6):497-509. Review. Japanese. No abstract available.

PMID:
9656245
17.

Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors.

Mazda O.

Curr Gene Ther. 2002 Sep;2(3):379-92. Review.

PMID:
12189722
18.

Oncogenes and anti-oncogenes in human central nervous system tumors.

Batra SK, Rasheed BK, Bigner SH, Bigner DD.

Lab Invest. 1994 Nov;71(5):621-37. Review. No abstract available.

PMID:
7967518
19.

Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma.

Llaguno SA, Chen J, Kwon CH, Parada LF.

Cold Spring Harb Symp Quant Biol. 2008;73:421-6. doi: 10.1101/sqb.2008.73.005. Epub 2008 Nov 6. Review.

PMID:
19022744
20.

Modeling cancer using genetically engineered mice.

Stiedl P, Grabner B, Zboray K, Bogner E, Casanova E.

Methods Mol Biol. 2015;1267:3-18. doi: 10.1007/978-1-4939-2297-0_1. Review.

PMID:
25636462
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk